Stay updated with breaking news from Stuart Connolly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic device, a global study has found.
The phase 4 ANNEXA-I trial was stopped early after showing superior hemostatic efficacy and the capability to limit potentially life-threatening intracerebral hemorrhage (ICH) compared with usual care in patients taking oral factor Xa (FXa) inhibitors.
A Dunfermline man failed to get treatment for his dog after it broke its leg.
While the new drug reduced hematoma expansion compared with usual care, it was also associated with an increase in thrombotic events in the ANNEXa-I study.
Tim Grant, CEO of Deus X Capital and Former Galaxy Executive, Joins ...